{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:28Z","timestamp":1792664608127,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07943-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:56:10Z","timestamp":1772628970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting neuropilin-1 and neutralizing interleukin-6 inhibits cancer stem cell formation in bladder cancer cells"],"prefix":"10.1186","volume":"24","author":[{"given":"Hsiao-Wen","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Kung","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Hsien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Jung","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-7456","authenticated-orcid":false,"given":"Shye-Jye","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"3","key":"7943_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"7943_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","volume":"17","author":"JJ Meeks","year":"2020","unstructured":"Meeks JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, Flaig TW, DeGraff DJ, et al. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat Rev Urol. 2020;17(5):259\u201370.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"7943_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"7943_CR4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"1","key":"7943_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"key":"7943_CR6","doi-asserted-by":"crossref","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. Embo J. 2021;40(18):e108647.","DOI":"10.15252\/embj.2021108647"},{"issue":"4","key":"7943_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"10","key":"7943_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"7943_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"7943_CR10","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1002\/jcp.26916","volume":"234","author":"N Aghaalikhani","year":"2019","unstructured":"Aghaalikhani N, Rashtchizadeh N, Shadpour P, Allameh A, Mahmoodi M. Cancer stem cells as a therapeutic target in bladder cancer. J Cell Physiol. 2019;234(4):3197\u2013206.","journal-title":"J Cell Physiol"},{"issue":"6","key":"7943_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbi.2010.03.009","volume":"24","author":"XS Wang","year":"2010","unstructured":"Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010;24(6):968\u201374.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"7943_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signaling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"7943_CR13","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1038\/s41467-021-26407-4","volume":"12","author":"EH Bent","year":"2021","unstructured":"Bent EH, Millan-Barea LR, Zhuang I, Goulet DR, Frose J, Hemann MT. Microenvironmental IL-6 inhibits anticancer immune responses generated by cytotoxic chemotherapy. Nat Commun. 2021;12(1):6218.","journal-title":"Nat Commun"},{"issue":"4","key":"7943_CR14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1073\/pnas.1018898108","volume":"108","author":"D Iliopoulos","year":"2011","unstructured":"Iliopoulos D, Hirsch HA, Wang GN, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. P Natl Acad Sci USA. 2011;108(4):1397\u2013402.","journal-title":"P Natl Acad Sci USA"},{"key":"7943_CR15","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1038\/ncomms10186","volume":"6","author":"T Kim","year":"2015","unstructured":"Kim T, Yang SJ, Hwang D, Song J, Kim M, Kyum Kim S, et al. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness. Nat Commun. 2015;6:10186.","journal-title":"Nat Commun"},{"issue":"12","key":"7943_CR16","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1182\/blood.V77.12.2794.2794","volume":"77","author":"H Ludwig","year":"1991","unstructured":"Ludwig H, Nachbaur DM, Fritz E, Krainer M, Huber H. Interleukin-6 is a prognostic factor in multiple myeloma. Blood. 1991;77(12):2794\u201395.","journal-title":"Blood"},{"issue":"7","key":"7943_CR17","first-page":"2702","volume":"6","author":"J Nakashima","year":"2000","unstructured":"Nakashima J, Tachibana M, Horiguchi Y, Oya M, Ohigashi T, Asakura H, Murai M. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res. 2000;6(7):2702\u201306.","journal-title":"Clin Cancer Res"},{"key":"7943_CR18","doi-asserted-by":"crossref","unstructured":"Chen MF, Lin PY, Wu CF, Chen WC, Wu CT. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One. 2013;8(4):e61901.","DOI":"10.1371\/journal.pone.0061901"},{"issue":"6","key":"7943_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","volume":"92","author":"S Soker","year":"1998","unstructured":"Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735\u201345.","journal-title":"Cell"},{"issue":"4","key":"7943_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/carcin\/bgq281","volume":"32","author":"Y Glinka","year":"2011","unstructured":"Glinka Y, Stoilova S, Mohammed N, Prud\u2019homme GJ. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis. 2011;32(4):613\u201321.","journal-title":"Carcinogenesis"},{"issue":"1","key":"7943_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/cr.2011.198","volume":"22","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Doci CL, Gutkind JS. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 2012;22(1):23\u201332.","journal-title":"Cell Res"},{"issue":"1","key":"7943_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.01.010","volume":"373","author":"M Luo","year":"2016","unstructured":"Luo M, Hou L, Li J, Shao S, Huang S, Meng D, et al. VEGF\/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kappaB and beta-catenin. Cancer Lett. 2016;373(1):1\u201311.","journal-title":"Cancer Lett"},{"issue":"7369","key":"7943_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature10525","volume":"478","author":"B Beck","year":"2011","unstructured":"Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A, et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature. 2011;478(7369):399\u2013403.","journal-title":"Nature"},{"issue":"33","key":"7943_CR24","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1038\/onc.2015.507","volume":"35","author":"D Grun","year":"2016","unstructured":"Grun D, Adhikary G, Eckert RL. VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors. Oncogene. 2016;35(33):4379\u201387.","journal-title":"Oncogene"},{"issue":"48","key":"7943_CR25","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/s41388-020-01462-1","volume":"39","author":"RS Angom","year":"2020","unstructured":"Angom RS, Mondal SK, Wang F, Madamsetty VS, Wang E, Dutta SK, et al. Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme. Oncogene. 2020;39(48):7114\u201326.","journal-title":"Oncogene"},{"issue":"6","key":"7943_CR26","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1007\/s13277-014-1806-3","volume":"35","author":"W Cheng","year":"2014","unstructured":"Cheng W, Fu D, Wei ZF, Xu F, Xu XF, Liu YH, et al. NRP-1 expression in bladder cancer and its implications for tumor progression. Tumour Biol. 2014;35(6):6089\u201394.","journal-title":"Tumour Biol"},{"issue":"9","key":"7943_CR27","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00262-022-03153-0","volume":"71","author":"Y Yu","year":"2022","unstructured":"Yu Y, Zeng H, Jin K, You R, Liu Z, Zhang H, et al. Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. Cancer Immunol Immunother. 2022;71(9):2117\u201326.","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"7943_CR28","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1158\/1078-0432.CCR-12-1652","volume":"18","author":"Y Xin","year":"2012","unstructured":"Xin Y, Li J, Wu J, Kinard R, Weekes CD, Patnaik A, et al. Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors. Clin Cancer Res. 2012;18(21):6040\u201348.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"7943_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/jm901755g","volume":"53","author":"A Jarvis","year":"2010","unstructured":"Jarvis A, Allerston CK, Jia H, Herzog B, Garza-Garcia A, Winfield N, et al. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor a (VEGF-A) interaction. J Med Chem. 2010;53(5):2215\u201326.","journal-title":"J Med Chem"},{"issue":"9","key":"7943_CR30","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1172\/JCI99257","volume":"128","author":"S Rizzolio","year":"2018","unstructured":"Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, et al. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies. J. Clin. Invest. 2018;128(9):3976\u201390.","journal-title":"J. Clin. Invest"},{"key":"7943_CR31","doi-asserted-by":"crossref","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9(5):e96801.","DOI":"10.1371\/journal.pone.0096801"},{"issue":"2","key":"7943_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10, 000 tumors from 33 types of cancer. Cell. 2018;173(2):291\u2013304 e6.","journal-title":"Cell"},{"key":"7943_CR33","doi-asserted-by":"publisher","first-page":"685980","DOI":"10.3389\/fonc.2021.685980","volume":"11","author":"Y Dong","year":"2021","unstructured":"Dong Y, Ma WM, Shi ZD, Zhang ZG, Zhou JH, Li Y, et al. Role of NRP1 in bladder cancer pathogenesis and progression. Front Oncol. 2021;11:685980.","journal-title":"Front Oncol"},{"key":"7943_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.humpath.2018.06.030","volume":"81","author":"Y Yang","year":"2018","unstructured":"Yang Y, Yang L, Li Y. Neuropilin-1 (NRP-1) upregulated by IL-6\/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms. Hum Pathol. 2018;81:192\u2013200.","journal-title":"Hum Pathol"},{"key":"7943_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-4598-9-9","volume":"9","author":"S Zhang","year":"2010","unstructured":"Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, Fan S, et al. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer. 2010;9:9.","journal-title":"Mol Cancer"},{"issue":"9","key":"7943_CR36","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41590-020-0733-2","volume":"21","author":"C Liu","year":"2020","unstructured":"Liu C, Somasundaram A, Manne S, Gocher AM, Szymczak-Workman AL, Vignali KM, et al. Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity. Nat Immunol. 2020;21(9):1010.","journal-title":"Nat Immunol"},{"issue":"11","key":"7943_CR37","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1111\/all.16285","volume":"79","author":"R Khalmuratova","year":"2024","unstructured":"Khalmuratova R, Ryu JS, Hwang JH, Kim YS, Lim S, Mo JH, et al. NRP1 antagonism as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. Allergy. 2024;79(11):3095\u2013107.","journal-title":"Allergy"},{"issue":"11","key":"7943_CR38","first-page":"3028","volume":"16","author":"TB Dorff","year":"2010","unstructured":"Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN, Van Veldhuizen PJ, et al. Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (Siltuximab). A Monoclonal Antibody against Interleukin-6, Chemother-Pretreated Patients Castration-Resistant Prostate Cancer. Clin Cancer Res. 2010;16(11):3028\u201334.","journal-title":"A Monoclonal Antibody against Interleukin-6, Chemother-Pretreated Patients Castration-Resistant Prostate Cancer. Clin Cancer Res"},{"issue":"6","key":"7943_CR39","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","volume":"21","author":"JF Rossi","year":"2015","unstructured":"Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21(6):1248\u201357.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"7943_CR40","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-11-3195","volume":"72","author":"PL Ho","year":"2012","unstructured":"Ho PL, Lay EJ, Jian W, Parra D, Chan KS. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res. 2012;72(13):3135\u201342.","journal-title":"Cancer Res"},{"issue":"34","key":"7943_CR41","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41388-018-0290-4","volume":"37","author":"D Grun","year":"2018","unstructured":"Grun D, Adhikary G, Eckert RL. NRP-1 interacts with GIPC1 and \u03b16\/\u03b24-integrins to increase YAP1\/\u0394Np63\u03b1-dependent epidermal cancer stem cell survival. Oncogene. 2018;37(34):4711\u201322.","journal-title":"Oncogene"},{"issue":"6","key":"7943_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41388-021-02119-3","volume":"41","author":"MJ Li","year":"2022","unstructured":"Li MJ, Rao XP, Cui Y, Zhang L, Li X, Wang BY, et al. The keratin 17\/YAP\/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer. Oncogene. 2022;41(6):770\u201381.","journal-title":"Oncogene"},{"issue":"1","key":"7943_CR43","first-page":"9","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4(1):9\u201326.","journal-title":"Nat Cancer"},{"key":"7943_CR44","doi-asserted-by":"crossref","unstructured":"Sadhukhan P, Feng M, Illingworth E, Sloma I, Ooki A, Matoso A, et al. YAP1 induces bladder cancer progression and promotes immune evasion through IL-6\/STAT3 pathway and CXCL deregulation. J. Clin. Invest. 2024;135(2).","DOI":"10.1172\/JCI171164"},{"key":"7943_CR45","doi-asserted-by":"crossref","unstructured":"He LZ, Pratt H, Gao MS, Wei FX, Weng ZP, Struhl K. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. Elife. 2021;10.","DOI":"10.7554\/eLife.67312"},{"issue":"7541","key":"7943_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14228","volume":"519","author":"K Taniguchi","year":"2015","unstructured":"Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, et al. A gp130-src-YAP module links inflammation to epithelial regeneration. Nature. 2015;519(7541):57\u201362.","journal-title":"Nature"},{"issue":"7","key":"7943_CR47","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.4161\/cbt.6.7.4328","volume":"6","author":"LW Feurino","year":"2007","unstructured":"Feurino LW, Zhang Y, Bharadwaj U, Zhang R, Li F, Fisher WE, et al. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther. 2007;6(7):1096\u2013100.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"7943_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/acsptsci.4c00663","volume":"8","author":"S Kumbham","year":"2025","unstructured":"Kumbham S, Md Mahabubur Rahman K, Foster BA, You Y. A comprehensive review of current approaches in bladder cancer treatment. ACS Pharmacol Transl Sci. 2025;8(2):286\u2013307.","journal-title":"ACS Pharmacol Transl Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07943-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07943-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:03:43Z","timestamp":1775822623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07943-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7943"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07943-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8052232\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were conducted following the NIH Guide for the Care and Use of Laboratory Animals and the ARRIVE Guidelines. The protocol was approved by the IACUC of National Yang Ming Chiao Tung University, Yang Ming Campus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of the manuscript in Journal of Translational Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"498"}}